Joseph Clay Thornton
CIK: 0002128794
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLOVER HEALTH INVESTMENTS, CORP. /DE
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 15, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sale(S)Direct4.6K shares at avg. $4.68$21K - Aug 17, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sale(S)Direct17.8K shares at avg. $4.39$78K - Aug 12, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Award(A)Direct54.3K shares- - Jul 15, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sale(S)Direct4.6K shares at avg. $4.67$22K - May 16, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Tax Payment(F)Direct16.9K shares at avg. $3.47$59K - Apr 15, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Tax Payment(F)Direct4.2K shares at avg. $2.04$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Sale(S) | 4,591 | $4.68 | $21,486 | Direct |
| Aug 17, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Sale(S) | 17,775 | $4.39 | $78,032 | Direct |
| Aug 12, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Award(A) | 54,347 | - | $0 | Direct |
| Jul 15, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Sale(S) | 4,630 | $4.67 | $21,622 | Direct |
| May 16, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Tax Payment(F) | 16,942 | $3.47 | $58,789 | Direct |
| Apr 15, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Tax Payment(F) | 4,158 | $2.04 | $8,482 | Direct |
1-6 of 6 transactions
About THORNTON JOSEPH CLAY
THORNTON JOSEPH CLAY (SEC CIK 0002128794) files insider reports with the SEC as Interim CFO of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
Signal8 holds 8 ownership filings by THORNTON JOSEPH CLAY (2 Form 3, 6 Form 4), filed between Apr 9, 2026 and Oct 19, 2026. Those filings report 6 transactions, from Apr 15, 2026 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on THORNTON JOSEPH CLAY's filings is in WILMINGTON, DE.
Recent filings by THORNTON JOSEPH CLAY
- Oct 15, 2026: Open-market sale of CLOV shares (Form 4, code S).
- Aug 17, 2026: Open-market sale of CLOV shares (Form 4, code S).
- Aug 12, 2026: Grant or award of CLOV shares (Form 4, code A).
- Jul 15, 2026: Open-market sale of CLOV shares (Form 4, code S).
- May 16, 2026: Tax withholding of CLOV shares (Form 4, code F).
Other insiders filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
- Soares Karen, Chief Legal Officer
- Reynoso Jamie L., CEO, Medicare Advantage
- Toy Andrew, Chief Executive Officer
- Wai Conrad, CEO, Counterpart Health
- Miller Brian James, Director
- Torricelli Robert G, Director